Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid Per Inhalation for Treatment of Pulmonary Hemorrhage in Pediatric Patients

NCT03676023 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT03676023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03676023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid Per Inhalation for Treatment of Pulmonary Hemorrhage in Pediatric Patients
Lead sponsor
Baylor College of Medicine
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
May 1, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mapca - major aortopulmonary collateral artery, pulmonary hemorrhage